Synthesis of metallo-β-Lactamase VIM-2 is associated with a fitness reduction in Salmonella enterica serovar Typhimurium

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 11, 2014, Pages 6528-6535

  Cordeiro, Nicolás F ^a   Chabalgoity, José A ^a   Yim, Lucía ^a   Vignoli, Rafael ^a  

^a DEPARTAMENTO DE BIOQUÍMICA   (Uruguay)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAZIDIME; IMIPENEM; METALLO BETA LACTAMASE; PROTEIN VIM 2; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; CARBAPENEMASE; VIM-2 BETA-LACTAMASE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CELL INVASION; CELL STRUCTURE; CONTROLLED STUDY; ENZYME SYNTHESIS; EPITHELIUM CELL; EPSILOMETER TEST; GROWTH RATE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; REPRODUCTIVE FITNESS; SALMONELLA TYPHIMURIUM; BIOSYNTHESIS; CACO 2 CELL LINE; CELL LINE; DRUG EFFECTS; GENETICS; HUMAN; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTIDRUG RESISTANCE; PATHOGENICITY; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; SALMONELLA INFECTIONS;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CACO-2 CELLS; CELL LINE; CLONING, MOLECULAR; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EPITHELIAL CELLS; GENETIC FITNESS; HUMANS; MICROBIAL SENSITIVITY TESTS; PLASMIDS; SALMONELLA INFECTIONS; SALMONELLA TYPHIMURIUM;

EID: 84908310911     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02847-14     Document Type: Article

References (36)

1. Pegues DA, Ohl ME, Millar SI. 2005. Salmonella species, including Salmonella typhi. In Mandell GL, Bennett JE, Dolin R (ed), Principles and practice of infectious diseases, 7th ed, vol 2. Elsevier, Philadelphia, Pa.
2. Guerrant RL, Van Gilder T, Steiner TS, Thielman NM, Slutsker L, Tauxe RV, Hennessy T, Griffin PM, DuPont H, Sack RB, Tarr P, Neill M, Nachamkin I, Reller LB, Osterholm MT, Bennish ML, Pickering LK. 2001. Practice guidelines for the management of infectious diarrhea. Clin. Infect. Dis. 32:331-350. http://dx.doi.org/10.1086/318514.
3. Boyle EC, Bishop JL, Grassl GA, Finlay BB. 2007. Salmonella: from pathogenesis to therapeutics. J. Bacteriol. 189:489-1495. http://dx.doi.org/10.1128/JB.01730-06.
4. Arlet G, Barrett TJ, Butaye P, Cloeckaert A, Mulvey MR, White DG. 2006. Salmonella resistant to extended-spectrum cephalosporins: prevalence and epidemiology. Microbes Infect. 8:1945-1954. http://dx.doi.org/10.1016/j.micinf.2005.12.029.
5. Jacoby GA. 2009. AmpC β-lactamases. Clin. Microbiol. Rev. 22:161-182. http://dx.doi.org/10.1128/CMR.00036-08.
6. Cordeiro NF, Yim L, Betancor L, Cejas D, García-Fulgueiras V, Mota MI, Varela G, Anzalone L, Algorta G, Gutkind G, Ayala JA, Chabalgoity JA, Vignoli R. 2013. Identification of the first blacmy-2 gene in Salmonella enterica serovar Typhimurium isolates obtained from cases of paediatric diarrhoea illness detected in South America. J. Global Antimicrobial Resistance. 1:143-148. http://dx.doi.org/10.1016/j.jgar.2013.04.003.
7. OXA-53) and 6′-N-aminoglycoside acetyltransferase genes [aac(6=)-I30]. J. Antimicrob. Chemother. 54:354-359. http://dx.doi.org/10.1093/jac/dkh347.
8. Michael GB, Cardoso M, Schwarz S. 2008. Molecular analysis of multiresistant porcine Salmonella enterica subsp. enterica serovar Bredeney isolates from Southern Brazil: identification of resistance genes, integrons and a group II intron. Int. J. Antimicrob. Agents 32:120-129. http://dx.doi.org/10.1016/j.ijantimicag.2008.02.024.
9. Le Hello S, Harrois D, Bouchrif B, Sontag L, Elhani D, Guibert V, Zerouali K, Weill FX. 2013. Highly drug-resistant Salmonella enterica serotype Kentucky ST198-X1: a microbiological study. Lancet Infect. Dis. 13:672-679. http://dx.doi.org/10.1016/S1473-3099(13)70124-5.
10. Savard P, Gopinath R, Wenming Z, Kitchel B, Rasheed JK, Tekle T, Roberts A, Ross T, Razeq J, Landrum BM, Wilson LE, Limbago B, Perl TM, Carroll KC. 2011. First NDM-positive Salmonella sp. strain identified in the United States. Antimicrob. Agents Chemother. 55:5957-5958. http://dx.doi.org/10.1128/AAC.05719-11.
11. Cabanes F, Lemant J, Picot S, Simac C, Cousty J, Jalin L, Naze F, Boisson V, Cresta MP, André H, Thibault L, Tixier F, Winer A, Antok E, Michault A. 2012. Emergence of Klebsiella pneumoniae and Salmonella metallo-β-lactamase (NDM-1) producers on Reunion Island. J. Clin. Microbiol. 50:3812-3813. http://dx.doi.org/10.1128/JCM.01029-12.
12. Huang J, Wang M, Ding H, Ye M, Hu F, Guo Q, Xu X, Wang M. 2013. New Delhi metallo-β-lactamase-1 in carbapenem-resistant Salmonella strain, China. Emerg. Infect. Dis. 19:2049-2051. http://dx.doi.org/10.3201/eid1912.130051.
13. Fischer J, Rodríguez I, Schmoger S, Friese A, Roesler U, Helmuth R, Guerra B. 2013. Salmonella enterica subsp. enterica producing VIM-1 carbapenemase isolated from livestock farms. J. Antimicrob. Chemother. 68:478-480. http://dx.doi.org/10.1093/jac/dks393.
14. Morosini MI, Ayala JA, Baquero F, Martinez JL, Blázquez J. 2000. Biological cost of AmpC production for Salmonella enterica serotype Typhimurium. Antimicrob. Agents Chemother. 44:3137-3143. http://dx.doi.org/10.1128/AAC.44.11.3137-3143.2000.
15. + for all three chromosomally located systems of DNA restriction and modification. J. Bacteriol. 156:471-474.
16. Hoiseth SK, Stocker BA. 1981. Aromatic-dependent Salmonella Typhimurium are non-virulent and effective as live vaccines. Nature 219:238-239.
17. Hanahan D. 1985. Techniques for transformation of E. coli, p. 109-135. In DM Glover (ed.), DNA cloning: a practical approach, vol. 1. IRL Press, McLean, VA.
18. Casadaban MJ, Cohen SH. 1980. Analysis of gene control signals by DNA fusion and cloning in Escherichia coli. J. Mol. Biol. 138:179-207. http://dx.doi.org/10.1016/0022-2836(80)90283-1.
19. Robino L, Scavone P, Araujo L, Algorta G, Zunino P, Vignoli R. 2013. Detection of intracellular bacterial communities in a child with Escherichia coli recurrent urinary tract infections. Pathog. Dis. 68:78-81. http://dx.doi.org/10.1111/2049-632X.12047.
20. Medina JC, Seija V, Vignoli R, Pontet J, Robino L, Cordeiro NF, Bado I, García-Fulgueiras V, Berro M, Bazet C, Savio E, Rieppi G. 2013. Polyclonal endemicity of Acinetobacter baumannii in ventilated patients in an intensive care unit in Uruguay. Int. J. Infect. Dis. 17:422-427. http://dx.doi.org/10.1016/j.ijid.2012.12.025.
21. VIM-2-harboring integrons isolated in India, Russia, and the United States arise from an ancestral class 1 integron predating the formation of the 3′ conserved sequence. Antimicrob. Agents Chemother. 51:2636-2638. http://dx.doi.org/10.1128/AAC.01043-06.
22. Sambrook J, Fritsch EF, Maniatis T. 1989. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
23. BAD promoter. J. Bacteriol. 177:4121-4130.
24. Datsenko KA, Wanner BL. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. U. S. A. 97:6640-6645. http://dx.doi.org/10.1073/pnas.120163297.
25. Vignoli R, Cordeiro NF, García V, Mota MI, Betancor L, Power P, Chabalgoity JA, Schelotto F, Gutkind G, Ayala JA. 2006. New TEM-derived extended-spectrum β-lactamase and its genomic context in plasmids from Salmonella enterica serovar Derby isolates from Uruguay. Antimicrob. Agents Chemother. 50:781-784. http://dx.doi.org/10.1128/AAC.50.2.781-784.2006.
26. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254. http://dx.doi.org/10.1016/0003-2697(76)90527-3.
27. Oberhofer TR, Towle DW. 1982. Evaluation of the rapid penicillinase paper strip for detection of β-lactamase. J. Clin. Microbiol. 15:196-199.
28. Clinical and Laboratory Standards Institute. 2014. Performance standards for antimicrobial susceptibility testing: 24th informational supplement M100-S24. Clinical and Laboratory Standards Institute, Wayne, PA.
29. -ΔΔCt method. Methods 25:402-408. http://dx.doi.org/10.1006/meth.2001.1262.
30. Goussard S, Courvalin P. 1999. Updated sequence information for TEM β-lactamase genes. Antimicrob. Agents Chemother. 43:367-370.
31. Medina C, Camacho EM, Flores A, Mesa-Pereira B, Santero E. 2011. Improved expression systems for regulated expression in Salmonella infecting eukaryotic cells. PLoS One 6:e23055. http://dx.doi.org/10.1371/journal.pone.0023055.
32. Fernández A, Pérez A, Ayala JA, Mallo S, Rumbo-Feal S, Tomás M, Poza M, Bou G. 2012. Expression of OXA-type and SFO-1 β-lactamases induces changes in peptidoglycan composition and affects bacterial fitness. Antimicrob. Agents Chemother. 56:1877-1884. http://dx.doi.org/10.1128/AAC.05402-11.
33. Marciano DC, Karkouti OY, Palzkill T. 2007. A fitness cost associated with the antibiotic resistance enzyme SME-1 β-lactamase. Genetics 176:2381-2392. http://dx.doi.org/10.1534/genetics.106.069443.
34. Misselwitz B, Barrett N, Kreibich S, Vonaesch P, Andritschke D, Rout S, Weidner K, Sormaz M, Songhet P, Horvath P, Chabria M, Vogel V, Spori DM, Jenny P, Hardt WF. 2012. Near surface swimming of Salmonella Typhimurium explains target-site selection and cooperative invasion. PLoS Pathog. 8:e1002810. http://dx.doi.org/10.1371/journal.ppat.1002810.
35. Yim L, Betancor L, Martínez A, Bryant C, Maskell D, Chabalgoity JA. 2011. Naturally occurring motility-defective mutants of Salmonella enterica serovar Enteritidis isolated preferentially from nonhuman rather than human sources. Appl. Environ. Microbiol. 77:7740-7748. http://dx.doi.org/10.1128/AEM.05318-11.
36. Borgianni L, Vandenameele J, Matagne A, Bini L, Bonomo RA, Frère JM, Rossolini GM, Docquier JD. 2010. Mutational analysis of Vim-2 reveals an essential determinant for metallo-β-lactamase stability and folding. Antimicrob. Agents Chemother. 54:3197-3204. http://dx.doi.org/10.1128/AAC.01336-09.